Diagnostic Challenges and Long-term Outcomes of Neuroendocrine Carcinoma of the Cervix: A Case Series.
Journal
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
ISSN: 1538-7151
Titre abrégé: Int J Gynecol Pathol
Pays: United States
ID NLM: 8214845
Informations de publication
Date de publication:
12 Dec 2023
12 Dec 2023
Historique:
pubmed:
6
11
2023
medline:
6
11
2023
entrez:
3
11
2023
Statut:
aheadofprint
Résumé
Neuroendocrine carcinomas (NECs) of the cervix are rare, aggressive malignancies that are challenging to diagnose and treat. They are high-grade lesions that often share features with poorly differentiated adenocarcinoma and squamous cell carcinoma. NECs are classified into large-cell or small-cell subtypes but can often have a mixed appearance or occur concurrently with a squamous or adenocarcinoma. Diagnosis is dependent on tissue sampling, histomorphology, and immunohistochemistry. Eight cases of NEC were retrieved from the Department of Pathology at our institution from 2008 to 2022. Tumor slides were reviewed and evaluated by 2 independent pathologists. Seven of 8 patients tested positive for neuroendocrine markers, including CD56, synaptophysin, and chromogranin. We discuss the diagnostic challenges, review the histopathology, and describe the treatment courses and clinical outcomes. This case series reveals that traditional markers, such as p16, p63, and p40, may be focally positive in NEC and should not be considered a confirmation of squamous cell carcinoma. Patient outcomes can be affected by delays in diagnosis, misdiagnosis, and inadequate treatment when NEC is not considered in the initial differential diagnosis.
Identifiants
pubmed: 37922936
doi: 10.1097/PGP.0000000000000983
pii: 00004347-990000000-00113
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Ambros RA, Park JS, Shah K V, et al. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol 1991;4:586–93.
Stoler MH, Mills SE, Gersell DJ, et al. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 1991;15:28–32.
Margolis B, Tergas AI, Chen L, et al. Natural history and outcome of neuroendocrine carcinoma of the cervix. Gynecol Oncol 2016;141:247–54.
Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther 2015;15:805–10.
Castle PE, Pierz A, Stoler MH. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecol Oncol 2018;148:422–9.
Alejo M, Alemany L, Clavero O, et al. Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases. Papillomavirus Res 2018;5:134–42.
Salvo G, Gonzalez Martin A, Gonzales NR, et al. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecologic Cancer 2019;29:986–95.
Elsherif S, Odisio EGLC, Faria S, et al. Imaging and staging of neuroendocrine cervical cancer. Abdominal Radioly 2018;43:3468–78.
WHO Classification of Tumours Editorial Board. Female Genital Tumours WHO Classification of Tumours, 5th edn. International Agency for Research on Cancer; 2020.
Tempfer CB, Tischoff I, Dogan A, et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC Cancer 2018;18:530.
Zhou C, Hayes MMM, Clement PB, et al. Small cell carcinoma of the uterine cervix. Cancer 1998;84:281–8.
Duan X, Ban X, Zhang X, et al. MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations. Eur Radiol 2016;26:4293–302.
Ho JC, Allen PK, Bhosale PR, et al. Diffusion-weighted magnetic resonance imaging as a predictor of outcome in cervical cancer after chemoradiation. Int J Radiation Oncol 2017;97:546–53.
Salvo G, Ramalingam P, Flores Legarreta A, et al. Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study. Int J Gynecologic Cancer 2021;31:495–501
Chen J, Macdonald OK, Gaffney DK. Incidence, Mortality, and Prognostic Factors of Small Cell Carcinoma of the Cervix. Obstetr Gynecol 2008;111:1394–402.
Ishikawa M, Kasamatsu T, Tsuda H, et al. Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: a multi-center retrospective study. Gynecol Oncol 2018;148:139–46.
Hoskins PJ, Swenerton KD, Pike JA, et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 2003;21:3495–501.
Chan JK, Loizzi V, Burger RA, et al. Prognostic factors in neuroendocrine small cell cervical carcinoma. Cancer 2003;97:568–74.
Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol 2011;122:190–8.
Frumovitz M, Munsell MF, Burzawa JK, et al. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small-cell neuroendocrine carcinoma of the cervix. Gynecol Oncol 2017;144:46–50.
McCusker ME, Coté TR, Clegg LX, et al. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol 2003;88:333–9.
Li JD, Zhuang Y, Li YF, et al. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-center study of 25 cases. J Clin Pathol 2011;64:1102–7.
Pocrnich CE, Ramalingam P, Euscher ED, et al. Neuroendocrine carcinoma of the endometrium. Am J Surg Pathol 2016;40:577–86.
Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 2018;31:1770–86.
University of Texas MD Anderson Cancer Center. Neuroendocrine Cervical Tumor Registry. Houston, TX. Accessed August 27, 2023. https://necervix.com